Ophthalmology - Phase1 (1)
|
Modality |
Indication |
Targets |
Stage |
Company |
Project No. |
Detail |
| 1 |
Phase 1 clinical study of first in class tie2 activator PMC.403 in patients with age.related macular degeneration |
| Antibody |
Macular degeneration |
TIE.2 |
Phase 1 |
Pharm Abcine Inc. |
RS-2023-00282791 |
|